-
Clinical Pharmacology: Advances and Applications
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope – a meta-analysis
Original Research
(2279) Views (450) Full article downloads
Authors: Srikanth Vallurupalli, Smita Das
Published Date September 2010
Volume 2010:2 Pages 163 - 167
DOI: http://dx.doi.org/10.2147/CPAA.S12873
Srikanth Vallurupalli1, Smita Das21Division of General Internal Medicine, Southern Illinois University School of Medicine, Springfield, IL, USA; 2Department of Kinesiology and Community Health, University of Illinois College of Medicine, Champaign, IL, USA
Background: Beta1 (B1) selective blockers have been widely used for the treatment of neurocardiogenic syncope though clinical trials have shown conflicting degrees of efficacy.
Objective: To study the clinical efficacy of B1 selective blockers compared to placebo in the treatment of neurocardiogenic syncope.
Methods: Four placebo controlled randomized studies were identified after search of existing English language literature. Review Manager (RevMan version 5, Oxford, England) was used for statistical calculations. Both random and fixed effects models were used for analysis.
Results: There was no demonstrable efficacy of B1 blockers compared to placebo even after a pre-specified sensitivity analysis. There was a trend towards more adverse events in the beta blocker group compared to placebo (OR = 2.03 CI = 0.83–3.95, P = 0.12).
Conclusion: There is no clinical evidence for justifying the use of B1 selective blockers in the treatment of adult neurocardiogenic syncope. These agents may in fact lead to a higher rate of adverse events compared to placebo.
Keywords: beta1 selective blockers, neurocardiogenic syncope
Other articles by Dr Srikanth Vallurupalli
Risk of acquired methemoglobinemia with different topical anesthetics during endoscopic procedures
Readers of this article also read:
Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells
Age-related disruption of the lamina dura: Evidence in the mandibular horizontal incompletely impacted third molar
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Erratum
Methemoglobinemia due to topical pharyngeal anesthesia during endoscopic procedures
Adverse drug reaction suggests by a clinical vignette
Erratum
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




